ERBB2 and cancer: Thus, we substantiated our key findings in an independent systemic model of HER2+ human cancer by studying the dynamic surface expression of PD-L1 in osteosarcoma and the antitumor function of CARζ/CPR41BB cells in vitro and after adoptive transfer in a 143B osteosarcoma model.